Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790MKenneth S. Thress, Geoffrey R. Oxnard, Cloud P. Paweletz et al.|Nature Medicine|2015Cited by 1.5k
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and MelanomaAleix Prat, Enriqueta Felip, Alejandro Navarro et al.|Cancer Research|2017Cited by 480
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancerCristina Cruz, Violeta Serra, Marta Castroviejo‐Bermejo et al.|Annals of Oncology|2018Cited by 424
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancerElena Élez, Rodrigo A. Toledo, Javier Ros et al.|Nature Medicine|2022Cited by 111
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrenceIsabel Puig, Héctor G. Pálmer, Cristina Eguizábal et al.|Journal of Clinical Investigation|2018Cited by 108